Join the Life Science Washington Institute and Fenwick for a discussion on the key considerations surrounding the receipt and disclosure of clinical data in the life sciences sector. Our speakers will cover disclosure obligations, financing impacts, and best practices to ensure compliance and strategic advantage. This session is designed to provide valuable insights for business professionals navigating this complex landscape.